BASILEA PHARMACEUTICALS

Dead / Abandoned — Abandoned — no statement of use filed (as of 28 Sept 2026)

What this means for you

This application is over — abandoned 28 Sept 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
97540286
Mark type
Word mark
Filed
08 Aug 2022
Published for opposition
27 Jun 2023
Abandoned
28 Sept 2026
Attorney of record
Evan A. Raynes

Goods and services

  • Class 001 — Chemicals: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
  • Class 005 — Pharmaceuticals: Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; all of the aforesaid for prescription only
  • Class 042 — Scientific and technological services: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Owner

Prosecution history

  • 28 Sept 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 28 Sept 2026 — ABANDONMENT - NO USE STATEMENT FILED
  • 25 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 24 Jun 2026 — SOU EXTENSION 5 GRANTED
  • 15 Feb 2026 — SOU EXTENSION 5 FILED
  • 24 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 16 Feb 2026 — SOU TEAS EXTENSION RECEIVED
  • 19 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 18 Aug 2025 — SOU EXTENSION 4 GRANTED
  • 18 Aug 2025 — SOU EXTENSION 4 FILED
  • 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
  • 13 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 13 Feb 2025 — SOU EXTENSION 3 GRANTED
  • 13 Feb 2025 — SOU EXTENSION 3 FILED
  • 12 Feb 2025 — SOU TEAS EXTENSION RECEIVED

View this trademark record on Rightsy